About us
Owl Manor Veterinary, a division of Owl Manor Medical, LLC (OMM), was launched in February 2015. Owl Manor Veterinary is a privately held medical device company dedicated to joint and soft tissue preservation of companion animals (equine and canine) through a combination of regenerative medicine, point-of-care autologous biologics, and complimentary technologies. Spanning nearly 20 years of development, Owl Manor Veterinary’s portfolio of regenerative medicine devices, including Pro-Stride APS, Restigen PRP, and CenTrate BMA Concentrate, offers point-of-care convenience with clinically demonstrated effectiveness. Our regenerative medicine devices process blood or bone marrow aspirate that is harvested from the animal and prepared on-site in less than 30 minutes. This offers convenience, peace-of-mind, and cost savings to the caregiver and owner.
MARK SCHINDEL
Mark Schindel is a medical technology executive experienced in marketing, sales, business development, strategic planning, and project management in both early-stage and established corporate environments. Mark’s experience spans the life science, biotech, and medical device industries, including positions at Tornier, Zimmer, Biomet, and Roche. Mark holds a B.S. from Purdue University and an MBA from Vanderbilt University.
SCOTT KING
Scott King is Founder and President of the Hanuman Medical, creating and patenting new medical technologies. In addition to founding and managing Islet Sheet Medical and PlasmaSeal, Scott was Wall Street’s first biotechnology industry analyst. Scott was educated at the College of the University of Chicago (S.B.) and Harvard University (M.A.).
RICK STORRS
Rick Storrs, PhD, has over 20 years of experience in cell biology, design, and engineering across industry and academia. Prior roles include VP R&D at Hanuman Medical, and as Chief of Operations at Cerco Medical, Sr. Scientist at Plasmaseal, and Lead Scientist at DepoTech. Rick is a co-inventor of more than a dozen patented... show more
technologies and author of numerous peer-reviewed papers. Rick was trained as a protein chemist at University of California, Berkeley (PhD, 1992) and drug delivery scientist (NIH Postdoctoral Fellow, Stanford).
RANDY DORIAN
Randy Dorian has four decades of experience in academic and industrial research and development. He has served in senior level research positions, including EVP at Hanuman Medical, CSO at Cerco Medical, SVP at PlasmaSeal, and Sr Scientist / Director at Transtech Medical. With expertise in biotechnology, biochemistry, applied mathematics, bioengineering design and fabrication, Randy hold more than 50 patents and has authored numerous academic papers. show more